research
Gilead
Website: gilead.com
Overview
Gilead Sciences, Inc. is a prominent American biopharmaceutical company based in Foster City, California. Founded in 1987 by Michael L. Riordan, Gilead specializes in the research, development, and marketing of antiviral drugs for serious viral diseases, including HIV/AIDS, hepatitis B and C, influenza, and COVID-19. The company went public in 1992 and has since grown to operate in over 20 countries with a large workforce.
Gilead offers a diverse range of antiviral medications, such as Viread and Truvada for HIV, ledipasvir/sofosbuvir for hepatitis C, and Tamiflu for influenza. The company has also expanded into cell therapy through its acquisition of Kite Pharma in 2017, focusing on cancer treatment. Gilead is committed to addressing public health challenges, with initiatives like the COMPASS Initiative® aimed at tackling the HIV epidemic in the Southern U.S. and programs that support affected communities.
Gilead offers a diverse range of antiviral medications, such as Viread and Truvada for HIV, ledipasvir/sofosbuvir for hepatitis C, and Tamiflu for influenza. The company has also expanded into cell therapy through its acquisition of Kite Pharma in 2017, focusing on cancer treatment. Gilead is committed to addressing public health challenges, with initiatives like the COMPASS Initiative® aimed at tackling the HIV epidemic in the Southern U.S. and programs that support affected communities.
Est Monthly Spend
---
Repeat Buy Rate
---
Direct Response
---
Est. Spend
No spend data available
Top Shows
Ads
Recent Campaigns